ROS-responsive drug delivery system with enhanced anti-angiogenic and anti-inflammatory properties for neovascular age-related macular degeneration therapy. [PDF]
Zuo J+8 more
europepmc +1 more source
Modeling angiogenesis under Robin boundary conditions
Abstract In this study, we show an example of a numerical model based on the Keller–Segel system of equations to simulate angiogenesis in response to chemotaxis under Robin boundary conditions, which represent the presence of flux at the tumor. Different parameters of the model are modified to identify key biological factors relevant to the behavior of
Pablo Álvarez‐Caudevilla+2 more
wiley +1 more source
Correlation of Circulating Complement Levels with Clinical Characteristics of Patients with Diabetic Retinopathy. [PDF]
Wang G, Guo Y.
europepmc +1 more source
Vascular Endothelial Growth Factors in Eye Diseases. Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis (Verisuonikasvutekijöiden merkitys silmäsairauksissa. Patofysiologiaa ja uusia hoitomenetelmiä verkkokalvon ja suonikalvon angiogeneettisiin sairauksiin) [PDF]
Kinnunen, Kati
core
Timed topical dexamethasone eye drops improve mitochondrial function to prevent severe retinopathy of prematurity. [PDF]
Yagi H+16 more
europepmc +1 more source
RNF213, a unique E3 ligase, plays a pivotal role in modulating the phosphorylation of key residues on the receptor tyrosine kinases EGFR and HER2 in response to EGF or TGFα stimulation. This receptor activation then selectively enhances the phosphorylation of downstream signaling effectors Src and PLCγ, but not that of other canonical regulators such ...
Intisar M. Fouad+9 more
wiley +1 more source
Emerging liposomal therapies for diabetic retinopathy: a review of novel targeting approaches and advances in retinal health outcomes. [PDF]
Parashar R, Suresh PK.
europepmc +1 more source
The Effect of Botulinum Toxin Type A in the Autologous Fat Grafting: A Review. [PDF]
Lo C, Cao L, Lin Y, Wang H.
europepmc +1 more source
NeoCast is a next‐generation, solvent‐free, non‐adhesive liquid embolic designed for indications where deep occlusion is desired (e.g., tumors and chronic subdural hematoma). This novel agent offers ideal embolic properties: injectability, controllability, excellent visibility, and biocompatibility.
Quynh P. Pham+16 more
wiley +1 more source